Thoracic Imaging of Non-Small Cell Lung Cancer Treated With Anti-programmed Death Receptor-1 Therapy

Treatment with anti-programmed death receptor-1 (PD-1) therapeutics can lead to unconventional responses and side effect profiles due to their potentiating effects on the immune system. Here we evaluate the radiologic manifestations of anti-PD-1 therapy in the chest in patients with non-small cell lung cancer (NSCLC) receiving anti-PD-1 therapy.

Source: Current Problems in Diagnostic Radiology - March 22, 2018 Category: Radiology Authors: Mark Hammer, Stephen Bagley, Charu Aggarwal, Joshua Bauml, Arun Nachiappan, Charles B. Simone, Corey Langer, Sharyn I. Katz Source Type: research